All In Biotech

Drug Trial Radar · NCT00098124

Study of Milnacipran for the Treatment of Fibromyalgia

A Phase III Pivotal, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Milnacipran for the Treatment of Fibromyalgia

Last checked: Nov 20, 2026Latest source record: Dec 24, 2007 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Title says "pivotal". Randomized with 1,200 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,200

Actual

Start

Nov 2004

Primary completion

Not stated

Study completion Dec 2006

Sponsor

Lead sponsor
Forest LaboratoriesAbbVie (ABBV)
Sponsor type
Industry
First posted
Dec 6, 2004

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Antidepressants of all varieties represent a common form of therapy for many chronic states including fibromyalgia. The majority of antidepressants increase the levels of serotonin or norepinephrine in the central nervous system. Milnacipran is a dual norepinephrine and serotonin reuptake inhibitor and may be effective in the treatment of fibromyalgia.

Conditions

  • Fibromyalgia

Interventions

  • milnacipran hydrochlorideDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Composite responder analysis based on pain and patient global status, with or without physical function.

Locations

80 sites in 1 country. Site status is shown where the registry gives one.

  • Forest Investigative Site

    Birmingham, Alabama

  • Forest Investigative Site

    Mobile, Alabama

  • Forest Investigative Site

    Montgomery, Alabama

  • Forest Investigative Site

    Peoria, Arizona

  • Forest Investigative Site

    Beverly Hills, California

  • Forest Investigative Site

    Sacramento, California

  • Forest Investigative Site

    San Diego, California

  • Forest Investigative Site

    San Diego, California

  • Forest Investigative Site

    Santa Ana, California

  • Forest Investigative Site

    Spring Valley, California

  • Forest Investigative Site

    Torrance, California

  • Forest Investigative Site

    Colorado Springs, Colorado

  • Forest Investigative Site

    Colorado Springs, Colorado

  • Forest Investigative Site

    Danbury, Connecticut

  • Forest Investigative Site

    Stamford, Connecticut

  • Forest Investigative Site

    Trumball, Connecticut

  • Forest Investigative Site

    Clearwater, Florida

  • Forest Investigative Site

    DeLand, Florida

  • Forest Investigative Site

    Delray Beach, Florida

  • Forest Investigative Site

    Jacksonville, Florida

  • Forest Investigative Site

    Ocala, Florida

  • Forest Investigative Site

    Ormond Beach, Florida

  • Forest Investigative Site

    Palm Harbor, Florida

  • Forest Investigative Site

    Pembroke Pines, Florida

  • Forest Investigative Site

    Port Orange, Florida

  • Forest Investigative Site

    Tamarac, Florida

  • Forest Investigative Site

    Decatur, Georgia

  • Forest Investigative Site

    Honolulu, Hawaii

  • Forest Investigative Site

    Meridian, Idaho

  • Forest Investigative Site

    Chicago, Illinois

  • Forest Investigative Site

    Libertyville, Illinois

  • Forest Investigative Site

    Peoria, Illinois

  • Forest Investigative Site

    Evansville, Indiana

  • Forest Investigative Site

    Lafayette, Indiana

  • Forest Investigative Site

    Wichita, Kansas

  • Forest Investigative Site

    Lexington, Kentucky

  • Forest Investigative Site

    Baltimore, Maryland

  • Forest Investigative Site

    Columbia, Maryland

  • Forest Investigative Site

    Frederick, Maryland

  • Forest Investigative Site

    Newton, Massachusetts

Showing 40 of 80 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.